MARSHALL WACE, LLP

Holdings History for Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

Symbol: TBPH on Nasdaq
Investment type: Equity / Ordinary Share $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$7,832,548	418,629	+60,978	+17%	$18.71	Q4 2025
30 Sep 2025	0.01%	+0%	$5,221,705	357,651	+256,873	+255%	$14.60	Q3 2025
30 Jun 2025	0%	+0%	$1,111,581	100,778	+85,867	+576%	$11.03	Q2 2025
31 Mar 2025	0%	-0%	$133,154	14,911	-51,156		$8.93	Q1 2025
31 Dec 2024	0%	-0%	$621,690	66,067	-83,993	-56%	$9.41	Q4 2024
30 Sep 2024	0%	-0%	$1,209,484	150,060	-147,439	-50%	$8.06	Q3 2024
30 Jun 2024	0%	+0%	$2,522,792	297,499	+135,426	+84%	$8.48	Q2 2024
31 Mar 2024	0%	+0%	$1,453,795	162,073	+162,073	NEW	$8.97	Q1 2024
31 Dec 2023		-0%	$0	0	-20,400	-100%	$19.99	Q4 2023
30 Sep 2023	0%	-0%	$176,052	20,400	-39,412	-66%	$8.63	Q3 2023
30 Jun 2023	0%	+0%	$619,054	59,812	+59,812	NEW	$10.35	Q2 2023
30 Sep 2020		-0%	$0	0	-14,990	-100%	$19.99	Q3 2020
30 Jun 2020	0%	+0%	$315,000	14,990	+14,990	NEW	$21.01	Q2 2020
30 Jun 2019		-0%	$0	0	-4,080	-100%	$19.99	Q2 2019
31 Mar 2019	0%	0%	$92,000	4,080	0		$22.55	Q1 2019
31 Dec 2018	0%	+0%	$104,000	4,080	+4,080	NEW	$25.49	Q4 2018
31 Mar 2017		-0.09%	$0	0	-408,880	-100%	$19.99	Q1 2017
31 Dec 2016	0.09%	+0.07%	$13,035,000	408,880	+329,812	+417%	$31.88	Q4 2016
30 Sep 2016	0.02%	+0.01%	$2,865,000	79,068	+55,362	+234%	$36.23	Q3 2016
30 Jun 2016	0%	+0%	$538,000	23,706	+23,706	NEW	$22.69	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.